glp 1 and diabetes GLP-1 Receptor Agonists as Treatments for Type 2 The role of GLP1 receptor

Pavli P, Triantafyllidou O, Kapantais E, Vlahos NF, Valsamakis G

The rising incidence of T2DM globally has further boosted the adoption of GLP-1 receptor agonists, especially as healthcare providers increasingly recommend these drugs due to their unique therapeutic benefits

To ensure robust comparisons, GLP-1 users were matched to non-users with similar demographic and clinical profiles, to create a control group of "digital twins"

[1] While there is no official link established between GLP-1 therapy and magnesium deficiency, the gastrointestinal side effects may theoretically increase the risk of suboptimal magnesium intake or absorption

Demkow U

doi: 10.1007/s12975-021-00887-4 93 RodeAKOBuusTBMrazVAl-JaberiFAHLopezDVFordSLet al